BibTex RIS Cite

Preparation and Characterization of Montmorillonite/Polycaprolactone Composite Scaffold Containing Strontium for Bone Tissue Engineering Studies

Year 2016, Volume: 3 Issue: 3, 669 - 682, 08.01.2017
https://doi.org/10.18596/jotcsa.287302

Abstract

Montmorillonite (MMT) has attracted much attention due to its intrinsic ability to incorporate cations. In this study, we developed scaffold combining strontium-modified MMT and polycaprolactone (SrMMT-PCL) to further utilise the osteoconductive properties of strontium. For this purpose, MMT was modified with strontium, and then blended with polycaprolactone (PCL) in specific ratios by using particulate leaching technique to obtain bone tissue-like biocomposite scaffold. The macrostructure and morphology were characterized by X-ray diffraction (XRD), fourier transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA) and scanning electron microscopy (SEM). The release of Sr2+ from scaffolds into cell culture medium was determined by inductive coupled plasma optical emission spectrometer (ICP-OES). The pore size distrubition of scaffolds was determined by mercury intrusion porosimetry. The mechanical properties were also evaluated. The results of FTIR and XRD confirmed intercalation of PCL into MMT layers. TGA studies concluded that the MMT in PCL promoted the thermal degradation of the matrix. ICP results showed that Sr2+ was released from composite scaffolds. The majority of pore volume seems to be occupied by pores around 250-350 mm. SEM observations demonstrated the macroporous structure of the MMT-PCL sponges obtained by using the particulate leaching method. As a result, gained data suggests that obtained tissue-engineered scaffold has the potential to serve as a suitable templete for bone tissue engineering applications.

References

  • References
  • Iroh O. Poly(epsilon-caprolactone), edited by J. E. Mark. Oxford Press, Oxford, 1999, pp. 361–362. ISBN: 0195107896.
  • Anirudhan TS, Sandeep, S. Synthesis and characterization of a novel pH-controllable composite hydrogel for anticancer drug delivery. New J. Chem. 2011; 35: 2869–2876. DOI: 10.1039/C1NJ20672A.
  • Aguzzi C, Cerezo P, Viseras C. Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 2007; 36: 22–36. DOI: 10.1016/j.clay.2006.06.015.
  • Ruiz-Hitzky E, Aranda P, Dardera M and Rytwob G. Hybrid materials based on clays for environmental and biomedical applications. J. Mater. Chem. 2010; 20: 9306–9321. DOI: 10.1039/c0jm00432d.
  • Bonnelye E, Chabadel A, Salte F, and Jurdic P. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008; 42: 129-138. DOI: 10.1016/j.bone.2007.08.043.
  • Dahl SG, Allan P, Marie PJ, Mauras Y, Boivin G, Ammann P, et al. Incorporation and distribution of strontium in bone. Bone. 2001; 28(4): 446–453. DOI: 10.1016/S8756-3282(01)00419-7.
  • Qiua K., Zhao XJ, Wana CX, Zhaoa CS, Chen YW. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials. 2006; 27: 1277–1286. DOI: 10.1016/j.biomaterials.2005.08.006.
  • Saltman PD, Strause LG. The role of trace minerals in osteoporosis. J Am Coll Nutr 1993;12(4):384-389. DOI: 10.1080/07315724.1993.10718327.
  • Beattie JH, Avenell A. Trace element nutrition and bone metabolism. Nutr Res Rev 1992;5(01):167-188. DOI: 10.1079/NRR19920013.
  • Nielsen F. New essential trace elements for the life sciences. Biol Trace Elem Res. 1990;26-27(1):599-611. DOI:10.1007/BF02992716.
  • Lakhkar NJ, Lee IH, Kim HW, Salih V, Wall IB, Knowles JC. Bone formation controlled by biologically relevant inorganic ions: Role and controlled delivery from phosphate-based glasses. Advanced Drug Delivery Reviews. 2013; 65: 405–420. DOI: 10.1016/j.addr.2012.05.015.
  • Loh QL and Choong C. Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size. Tissue Eng Part B Rev. 2013; 19(6): 485–502. DOI: 10.1089/ten.teb.2012.0437.
  • Roosa SMM, Kemppainen JM, Moffitt EN, Krebsbach PH, Hollister SJ. The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J. Biomed. Mater. Res. A. 2010; 92: 359–368. DOI: 10.1002/jbm.a.32381.
  • Burg KJL, Holder WD, Culberson CR, et al. Comparative Study of Seeding Methods for Three-Dimensional Polymeric Scaffolds, J. Biomed. Mater. Res. 2000; 51: 562–649. DOI: 10.1002/1097-4636(20000915)51:4<642:AID-JBM12>3.0.CO;2-L.
Year 2016, Volume: 3 Issue: 3, 669 - 682, 08.01.2017
https://doi.org/10.18596/jotcsa.287302

Abstract

References

  • References
  • Iroh O. Poly(epsilon-caprolactone), edited by J. E. Mark. Oxford Press, Oxford, 1999, pp. 361–362. ISBN: 0195107896.
  • Anirudhan TS, Sandeep, S. Synthesis and characterization of a novel pH-controllable composite hydrogel for anticancer drug delivery. New J. Chem. 2011; 35: 2869–2876. DOI: 10.1039/C1NJ20672A.
  • Aguzzi C, Cerezo P, Viseras C. Caramella C. Use of clays as drug delivery systems: possibilities and limitations. Appl. Clay Sci. 2007; 36: 22–36. DOI: 10.1016/j.clay.2006.06.015.
  • Ruiz-Hitzky E, Aranda P, Dardera M and Rytwob G. Hybrid materials based on clays for environmental and biomedical applications. J. Mater. Chem. 2010; 20: 9306–9321. DOI: 10.1039/c0jm00432d.
  • Bonnelye E, Chabadel A, Salte F, and Jurdic P. Dual effect of strontium ranelate: stimulation of osteoblast differentiation and inhibition of osteoclast formation and resorption in vitro. Bone 2008; 42: 129-138. DOI: 10.1016/j.bone.2007.08.043.
  • Dahl SG, Allan P, Marie PJ, Mauras Y, Boivin G, Ammann P, et al. Incorporation and distribution of strontium in bone. Bone. 2001; 28(4): 446–453. DOI: 10.1016/S8756-3282(01)00419-7.
  • Qiua K., Zhao XJ, Wana CX, Zhaoa CS, Chen YW. Effect of strontium ions on the growth of ROS17/2.8 cells on porous calcium polyphosphate scaffolds. Biomaterials. 2006; 27: 1277–1286. DOI: 10.1016/j.biomaterials.2005.08.006.
  • Saltman PD, Strause LG. The role of trace minerals in osteoporosis. J Am Coll Nutr 1993;12(4):384-389. DOI: 10.1080/07315724.1993.10718327.
  • Beattie JH, Avenell A. Trace element nutrition and bone metabolism. Nutr Res Rev 1992;5(01):167-188. DOI: 10.1079/NRR19920013.
  • Nielsen F. New essential trace elements for the life sciences. Biol Trace Elem Res. 1990;26-27(1):599-611. DOI:10.1007/BF02992716.
  • Lakhkar NJ, Lee IH, Kim HW, Salih V, Wall IB, Knowles JC. Bone formation controlled by biologically relevant inorganic ions: Role and controlled delivery from phosphate-based glasses. Advanced Drug Delivery Reviews. 2013; 65: 405–420. DOI: 10.1016/j.addr.2012.05.015.
  • Loh QL and Choong C. Three-Dimensional Scaffolds for Tissue Engineering Applications: Role of Porosity and Pore Size. Tissue Eng Part B Rev. 2013; 19(6): 485–502. DOI: 10.1089/ten.teb.2012.0437.
  • Roosa SMM, Kemppainen JM, Moffitt EN, Krebsbach PH, Hollister SJ. The pore size of polycaprolactone scaffolds has limited influence on bone regeneration in an in vivo model. J. Biomed. Mater. Res. A. 2010; 92: 359–368. DOI: 10.1002/jbm.a.32381.
  • Burg KJL, Holder WD, Culberson CR, et al. Comparative Study of Seeding Methods for Three-Dimensional Polymeric Scaffolds, J. Biomed. Mater. Res. 2000; 51: 562–649. DOI: 10.1002/1097-4636(20000915)51:4<642:AID-JBM12>3.0.CO;2-L.
There are 15 citations in total.

Details

Journal Section Articles
Authors

Aysel Koc Demir

Publication Date January 8, 2017
Submission Date July 1, 2016
Published in Issue Year 2016 Volume: 3 Issue: 3

Cite

Vancouver Koc Demir A. Preparation and Characterization of Montmorillonite/Polycaprolactone Composite Scaffold Containing Strontium for Bone Tissue Engineering Studies. JOTCSA. 2017;3(3):669-82.